Dr James G Cormack, MD | |
88 Mcgregor St, Ste 303, Manchester, NH 03102-3750 | |
(603) 647-9325 | |
(603) 647-2453 |
Full Name | Dr James G Cormack |
---|---|
Gender | Male |
Speciality | Anesthesiology |
Experience | 37 Years |
Location | 88 Mcgregor St, Manchester, New Hampshire |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1508862111 | NPI | - | NPPES |
30204188 | Medicaid | NH |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207L00000X | Anesthesiology | 12098 (New Hampshire) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Portsmouth Regional Hospital | Portsmouth, NH | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Portsmouth Anesthesia Associates Pa | 6002855327 | 44 |
News Archive
In a study of 1000 adult patients with unplanned admission to a tertiary hospital in Singapore, the prevalence of adverse drug reactions (ADRs) at the time of admission was 12.4 percent, and the prevalence of ADRs causing admission to the hospital was 8.1 percent.
Researchers need to proactively engage lesbian, gay, bisexual, and transgender people in health studies and collect data on these populations to identify and better understand health conditions that affect them, says a new report from the Institute of Medicine.
The American Thoracic Society has developed clinical practice guidelines to help clinicians identify and manage patients with sickle cell disease who are at increased risk for mortality from pulmonary hypertension.
Aegerion Pharmaceuticals, Inc., an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat severe lipid disorders, announced its financial results and business highlights for the third quarter ended September 30, 2010.
Researchers at the University of Alabama at Birmingham (UAB) report that children with cerebral palsy who underwent Constraint Induced Movement therapy (CI therapy) saw a significant increase in grey matter volume in areas of the brain associated with movement.
› Verified 9 days ago
Entity Name | Anesthesia Care Group Pc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1629074224 PECOS PAC ID: 5395646178 Enrollment ID: O20040115000446 |
News Archive
In a study of 1000 adult patients with unplanned admission to a tertiary hospital in Singapore, the prevalence of adverse drug reactions (ADRs) at the time of admission was 12.4 percent, and the prevalence of ADRs causing admission to the hospital was 8.1 percent.
Researchers need to proactively engage lesbian, gay, bisexual, and transgender people in health studies and collect data on these populations to identify and better understand health conditions that affect them, says a new report from the Institute of Medicine.
The American Thoracic Society has developed clinical practice guidelines to help clinicians identify and manage patients with sickle cell disease who are at increased risk for mortality from pulmonary hypertension.
Aegerion Pharmaceuticals, Inc., an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat severe lipid disorders, announced its financial results and business highlights for the third quarter ended September 30, 2010.
Researchers at the University of Alabama at Birmingham (UAB) report that children with cerebral palsy who underwent Constraint Induced Movement therapy (CI therapy) saw a significant increase in grey matter volume in areas of the brain associated with movement.
› Verified 9 days ago
Entity Name | Portsmouth Anesthesia Associates Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1568584290 PECOS PAC ID: 6002855327 Enrollment ID: O20050427000080 |
News Archive
In a study of 1000 adult patients with unplanned admission to a tertiary hospital in Singapore, the prevalence of adverse drug reactions (ADRs) at the time of admission was 12.4 percent, and the prevalence of ADRs causing admission to the hospital was 8.1 percent.
Researchers need to proactively engage lesbian, gay, bisexual, and transgender people in health studies and collect data on these populations to identify and better understand health conditions that affect them, says a new report from the Institute of Medicine.
The American Thoracic Society has developed clinical practice guidelines to help clinicians identify and manage patients with sickle cell disease who are at increased risk for mortality from pulmonary hypertension.
Aegerion Pharmaceuticals, Inc., an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat severe lipid disorders, announced its financial results and business highlights for the third quarter ended September 30, 2010.
Researchers at the University of Alabama at Birmingham (UAB) report that children with cerebral palsy who underwent Constraint Induced Movement therapy (CI therapy) saw a significant increase in grey matter volume in areas of the brain associated with movement.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Dr James G Cormack, MD 88 Mcgregor St, Ste 303, Manchester, NH 03102-3750 Ph: (603) 647-9325 | Dr James G Cormack, MD 88 Mcgregor St, Ste 303, Manchester, NH 03102-3750 Ph: (603) 647-9325 |
News Archive
In a study of 1000 adult patients with unplanned admission to a tertiary hospital in Singapore, the prevalence of adverse drug reactions (ADRs) at the time of admission was 12.4 percent, and the prevalence of ADRs causing admission to the hospital was 8.1 percent.
Researchers need to proactively engage lesbian, gay, bisexual, and transgender people in health studies and collect data on these populations to identify and better understand health conditions that affect them, says a new report from the Institute of Medicine.
The American Thoracic Society has developed clinical practice guidelines to help clinicians identify and manage patients with sickle cell disease who are at increased risk for mortality from pulmonary hypertension.
Aegerion Pharmaceuticals, Inc., an emerging biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat severe lipid disorders, announced its financial results and business highlights for the third quarter ended September 30, 2010.
Researchers at the University of Alabama at Birmingham (UAB) report that children with cerebral palsy who underwent Constraint Induced Movement therapy (CI therapy) saw a significant increase in grey matter volume in areas of the brain associated with movement.
› Verified 9 days ago
Rebecca Elizabeth Kadish, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 100 Hitchcock Way, Manchester, NH 03104 Phone: 603-695-2500 | |
Sean E Hunt, M.D. Anesthesiology Medicare: Medicare Enrolled Practice Location: 100 Hitchcock Way, Manchester, NH 03104 Phone: 603-695-2500 | |
Dr. Charles Beck Eastwood, M.D., C.M. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Elliot Way, Suite 200, Manchester, NH 03103 Phone: 603-663-2315 | |
Alan Mekler, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1 Elliot Way, Suite 200, Manchester, NH 03103 Phone: 603-663-2315 Fax: 603-647-9180 | |
Corinne E Cambio, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 100 Hitchcock Way, Manchester, NH 03104 Phone: 603-650-5922 | |
Dennis L Kelly, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 88 Mcgregor St, Ste 303, Manchester, NH 03102 Phone: 603-647-9325 Fax: 603-647-2453 | |
Martin Leonard Ginsberg, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 1 Elliot Way, Suite 200, Manchester, NH 03103 Phone: 603-663-2315 Fax: 603-647-9180 |